Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials
about
Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials
description
scientific article published on 18 August 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2018
@uk
name
Measurement of coagulation fac ...... ults from two crossover trials
@en
Measurement of coagulation fac ...... ults from two crossover trials
@nl
type
label
Measurement of coagulation fac ...... ults from two crossover trials
@en
Measurement of coagulation fac ...... ults from two crossover trials
@nl
prefLabel
Measurement of coagulation fac ...... ults from two crossover trials
@en
Measurement of coagulation fac ...... ults from two crossover trials
@nl
P2093
P2860
P50
P356
P1476
Measurement of coagulation fac ...... ults from two crossover trials
@en
P2093
Michiel Coppens
Saskia Middeldorp
Willem M Lijfering
Yuk W Cheung
P2860
P304
P356
10.1002/RTH2.12142
P407
P577
2018-08-18T00:00:00Z